Gene Therapy in CNS Disorder Market to Reach USD 25 Billion by 2035 at 14.2% CAGR
Gene Therapy in CNS Disorder Market Overview The Gene Therapy in CNS Disorder Market is expanding as advances in genetic engineering and gene-editing technologies create new opportunities for treating complex central nervous system disorders. Increasing prevalence of neurodegenerative diseases, growing … Read more